A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer

Anti-Cancer Drugs

Volumn 20, Issue 10, 2009, Pages 941-945

  Li, Maoquan ^a   Zhang, Jiaxing ^a   Wang, Daoyuan ^a   Zhong, Baoliang ^b   Tucker, Steven ^c   Lu, Chenhui ^a   Cheng, Jie ^a   Cao, Chuanwu ^a   Xu, Jiahua ^a   Xu, Jichong ^a   Pan, Hui ^a  

^a TONGJI UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c Pacific Cancer Centre   (Singapore)

Author keywords

5 fluorouracil; Advanced gastric cancer; Cisplatin; Intra arterial infusion chemotherapy; Mitomycin C

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LETHARGY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PALMAR PLANTAR ERYTHEMA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM METASTASIS; NEUTROPENIA; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 73349119643     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328331af3a     Document Type: Article

References (19)

1. Jemal A, Siegel R,Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
2. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993; 72:37-41.
3. Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with nonresectable gastric cancer. Br J Cancer 1995; 71:587-591.
4. Schipper DL, Wagener DJ. Chemotherapy of gastric cancer. Anti-cancer Drugs 1996; 7:137-149.
5. Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997; 8:163-168.
6. Kosaka T, Takano Y, Nakano Y, Akiyama T, Kiriyama M, Tomita F, et al. Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer. Gan To Kagaku Ryoho 1993; 20:1665-1668.
7. Kosaka T, Ueshige N, Sugaya J, Nakano Y, Akiyama T, Tomita F, et al. Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer. Gan To Kagaku Ryoho 1998; 25:1288-1291.
8. Stephens FO, Johnson AW, Crea E. Pre-operative basal chemotherapy in the management of cancer of the stomach. Med J Aust 1984; 140:143-147.
9. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989; 10:1-10.
10. Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol 2006; 24:2188-2196.
11. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006; 24:4991-4997.
12. Bobbio-Pallavicini E, Tacconi F, Porta C, Brambilla G, Mainardi E, Bianchessi C, Moroni M. Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study. Oncol Rep 2001; 8:167-171.
13. Kikuyama S, Inada T, Oyama R, Ogata Y. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer. Anticancer Res 2002; 22:3633-3636.
14. Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002; 20:1996-2004. (Pubitemid 34413593)
15. Cascinu S, Baldelli AM, Catalano V, Giordani P, Beretta GD, Silva RR, et al. Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen. Br J Cancer 2002; 86:213-217.
16. Tokairin Y, Maruyama M, Baba H, Yoshida T, Kure N, Nagahama T, Ebuchi M. Pharmacokinetics of subselective arterial infusion chemotherapy. Gan To Kagaku Ryoho 2001; 28:1795-1798.
17. Shchepotin IB, Evans STR, Chorny V, Ugrinov O, Osinsky S, Galakhin K, et al. Pre-operative superselective intra-arterial chemotherapy in the combined treatment of gastric carcinoma. Oncol Rep 1995; 2:473-479.
18. Liu FK. The interventional therapy for advanced gastric cancer before and after operation. Zhongguo Shiyong Waike Zazhi 2001; 21:403-405.
19. Masuyama M, Taniguchi H, Takeuchi K, Miyata K, Koyama H, Tanaka H, et al. Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy. Gan To Kagaku Ryoho 1994; 21:2253-2255.